| Govinda Brahmanday, MD | |
|
1236 Huffman Mill Rd, Burlington, NC 27215-8700 | |
| (336) 538-7725 | |
| Not Available |
| Full Name | Govinda Brahmanday |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 1236 Huffman Mill Rd, Burlington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679788962 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2015-00922 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice And Palliative Care Of Greensboro | Greensboro, NC | Hospice |
| Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
| Alamance Regional Medical Center | Burlington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Moses H Cone Memorial Hospital Operating Corporation | 6204744600 | 496 |
News Archive
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal)
Fifty years of medical studies show that sun exposure is a primary component in the development of melanoma, the most serious and deadly type of skin cancer, report leading dermatologists in the April 2006 issue of Dermatologic Surgery.
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
› Verified 5 days ago
| Entity Name | The Moses H Cone Memorial Hospital Operating Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356372064 PECOS PAC ID: 6204744600 Enrollment ID: O20031204000940 |
News Archive
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal)
Fifty years of medical studies show that sun exposure is a primary component in the development of melanoma, the most serious and deadly type of skin cancer, report leading dermatologists in the April 2006 issue of Dermatologic Surgery.
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
› Verified 5 days ago
| Entity Name | Alamance Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326010273 PECOS PAC ID: 5294647145 Enrollment ID: O20040504000878 |
News Archive
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal)
Fifty years of medical studies show that sun exposure is a primary component in the development of melanoma, the most serious and deadly type of skin cancer, report leading dermatologists in the April 2006 issue of Dermatologic Surgery.
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Govinda Brahmanday, MD Po Box 3810, Joplin, MO 64803-3810 Ph: (417) 347-4000 | Govinda Brahmanday, MD 1236 Huffman Mill Rd, Burlington, NC 27215-8700 Ph: (336) 538-7725 |
News Archive
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal)
Fifty years of medical studies show that sun exposure is a primary component in the development of melanoma, the most serious and deadly type of skin cancer, report leading dermatologists in the April 2006 issue of Dermatologic Surgery.
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
› Verified 5 days ago
Dr. Ayesha Ali, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 729 Meadowood Dr, Burlington, NC 27215 Phone: 347-606-0485 | |
Mr. Dwayne Dennis Callwood, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1234 Huffman Mill Road, Burlington, NC 27215 Phone: 336-538-2374 Fax: 336-584-6811 | |
Dr. Fozia Muhstaqe Khan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2991 Crouse Ln, Burlington, NC 27215 Phone: 336-586-0994 Fax: 336-586-9363 | |
Dr. Muhammad Arida, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1236 Huffman Mill Rd Ste 130, Burlington, NC 27215 Phone: 336-438-1060 | |
Janak Kantilal Choksi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1236 Huffman Mill Rd, Suite #120, Burlington, NC 27215 Phone: 336-538-7725 Fax: 336-538-7785 | |
Dr. Anna Melissa Solum, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1234 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-1234 Fax: 336-538-2390 | |
Dr. Munsoor Lateef, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2903 Professional Park Dr, Suite D, Burlington, NC 27215 Phone: 336-584-4913 Fax: 336-584-4914 |